Health Workssp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-04-19
Share capital
5,050.00 PLN
Registered address
ul. Sarmacka 19/124, 02-972 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 299 days for 2022), 1 not filed.

  • 202519/06/2026
  • 2024not filed
  • 202309/05/2024
  • 202209/05/2024
  • 202109/06/2022
  • 202024/06/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Manufacture of pharmaceutical preparations132 / 184
Top 72%
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations154 / 231
Top 67%
Sector · Manufacturing17,574 / 24,479
Top 72%
City · Warszawa28,863 / 56,980
Top 51%
Voivodeship · Mazowieckie40,247 / 77,137
Top 52%
Country · Poland159,854 / 297,935
Top 54%

Results vs industry

Revenue
This companyUSD 226.53kMedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD -62.42kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 288.09kMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 384.06kMedianUSD 897.46kAverageUSD 31.52m

Industry

Trademarks

Health Works holds 4 active trademarks registered with the Polish Patent Office. The first mark was filed in 2018.

MarkNumberClassesStatusProtected until
Nutrizen(word)Z.5494315Protected Nov 21, 2032
Nutriformin(word)Z.5230585Protected Jan 12, 2031
Nutrivimix(word)Z.4936525Protected Dec 10, 2028
Hashimoto PlanZ.4889425, 41Protected Aug 1, 2028
MarkProtected until
Nutrizen(word)Nov 21, 2032
Nutriformin(word)Jan 12, 2031
Nutrivimix(word)Dec 10, 2028
Hashimoto PlanAug 1, 2028

Authorized Representatives

Małgorzata Anna Mazur – Management Board Member

Manner of representation

In the case of a multi-member management board, joint action by two members of the management board or one member of the management board jointly with a commercial proxy is required for making declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
Jakub Łuszczykage 43
11$148.5710.8911%
Małgorzata Anna Mazurage 53
90$1,215.5689.1089%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-11-13.

  • mBank
    mBank
    44 1140 2004 0000 3502 7759 5769

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

Name
Anpharm Przedsiębiorstwo FarmaceutyczneS.A.
Tarchomińskie Zakłady Farmaceutyczne PolfaS.A.
VercoS.A.
MedicofarmaS.A.
VitamaS.A.
Munar PharmaS.A.
Sanford Biotechsp. z o.o.
Cefeasp. z o.o.
Auxilius PharmaS.A.
Stg25Branch (foreign co.)

Change history

DateEvent
2020-03-26Share capital increase
2018-06-28Address change
2018-04-19Entered in the register

FAQ

Last updated: 2026-06-19